Date:June 22, 2026

Great to connect with Dr. Delese Mimi Darko, Director General of the African Medicines Agency (AMA), and Senior Advisor Prof. Alex Dodoo this week.
We commend AMA’s progress in strengthening regulatory alignment across Africa – critical as patients continue to face substandard and falsified medicines. Strong oversight is essential to protect public health.
Equally important is building a consistent supply chain of quality, affordable medicines through strengthened local manufacturing, production, and distribution of essential, locally produced products.
Bio Usawa stands ready to work alongside AMA, national regulatory authorities, and committed partners to help unlock Africa’s full biotech potential. The opportunity – and responsibility – is clear: together, we can transform access to safe, high-quality medicines.
We call on stakeholders across sectors to step forward and collaborate now to turn this vision into reality.

At the Grand Challenges Annual Meeting 2026 in London, a clear and urgent theme emerged: Africa’s future in biotechnology will be defined not by a short…
June 2026Prof. Nazik Hammad, Bio Usawa’s Chief Medical Officer for Oncology, recently visited the company’s emerging manufacturing facility in the Kigali Special…
June 2026Bio Usawa Biotechnology is pleased to welcome its CEO and President to Kigali as part of the company’s ongoing scientific and operational activities in …
June 2026